ArticleInfectious disease reports2022
Evaluating the Use of Dalbavancin for Off-Label Indications.
Katherine Taylor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it
ArticleInfectious disease reports2022
Katherine Taylor et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.